Formic Acid

Formic Acid

SCHEMBL30838071

Cc1nc(NCC2CN(C)CCO2)ncc1-c1ccc(C(F)(F)F)cc1F.O=CO

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC8 Q9BY41 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ IRAK4 Q9NWZ3 1/20 0.39
▸ ACKR3 P25106 1/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ CYP11B1 P15538 6/20 0.36
▸ CYP11B2 P19099 6/20 0.36
▸ RAF1 P04049 2/20 0.36
▸ BRAF P15056 2/20 0.36
▸ HRH4 Q9H3N8 3/20 0.35
▸ AXL P30530 1/20 0.35
▸ FLT3 P36888 1/20 0.35
▸ TYRO3 Q06418 1/20 0.35
▸ MERTK Q12866 1/20 0.35
▸ WNT1 P04628 1/20 0.34
▸ GSK3B P49841 1/20 0.34
▸ DYRK1A Q13627 1/20 0.34
▸ MAP3K12 Q12852 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27137336 0.95 IRAK4 (0.42) HDAC1HDAC8HDAC6IRAK4ACKR3
SCHEMBL27095184 0.95 IRAK4 (0.42) HDAC1HDAC8HDAC6IRAK4ACKR3
Fumaric Acid SCHEMBL30838053 0.93 IRAK4 (0.38) HDAC1HDAC8HDAC6IRAK4ACKR3
Fumaric Acid SCHEMBL30838000 0.93 IRAK4 (0.38) HDAC1HDAC8HDAC6IRAK4ACKR3
Formic Acid SCHEMBL30838087 0.87 HRH4 (0.41) CYP11B1CYP11B2HRH4AXLFLT3
Formic Acid SCHEMBL30838066 0.86 HRH4 (0.44) CYP11B1CYP11B2HRH4AXLFLT3
Formic Acid SCHEMBL30838073 0.85 PRKCQ (0.41) CYP11B1CYP11B2HRH4
Hydrochloric Acid SCHEMBL30837998 0.81 PDE10A (0.42) HDAC1HDAC8HDAC6IRAK4ACKR3
Formic Acid SCHEMBL30838102 0.78 VNN1 (0.55) CYP11B1CYP11B2
Formic Acid SCHEMBL30838050 0.78 VNN1 (0.55) CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240059677-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES AS NICOTINIC ACETYLCHOLINESTERASE RECEPTOR ALPHA 6 MODULATOR CEREVANCE LTD (GB) 2024-02-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240059677-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES AS NICOTINIC ACETYLCHOLINESTERASE RECEPTOR ALPHA 6 MODULATOR CHRNA6, CHRM2, CHRNA1 HDAC1 1396/4885HDAC8 2499/4885HDAC6 2473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback